These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 26556851)
41. Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles. Lee HJ; Cho HY; Oh JH; Namkoong K; Lee JG; Park JM; Lee SS; Huh N; Choi JW Biosens Bioelectron; 2013 Sep; 47():508-14. PubMed ID: 23628845 [TBL] [Abstract][Full Text] [Related]
42. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372 [TBL] [Abstract][Full Text] [Related]
43. Enumeration of Circulating Tumor Cells and Disseminated Tumor Cells in Blood and Bone Marrow by Immunomagnetic Enrichment and Flow Cytometry (IE/FC). Magbanua MJM; Solanki TI; Ordonez AD; Hsiao F; Park JW Methods Mol Biol; 2017; 1634():203-210. PubMed ID: 28819853 [TBL] [Abstract][Full Text] [Related]
44. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets. Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566 [TBL] [Abstract][Full Text] [Related]
45. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Tewes M; Aktas B; Welt A; Mueller S; Hauch S; Kimmig R; Kasimir-Bauer S Breast Cancer Res Treat; 2009 Jun; 115(3):581-90. PubMed ID: 18679793 [TBL] [Abstract][Full Text] [Related]
46. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs). Hyun KA; Lee TY; Lee SH; Jung HI Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749 [TBL] [Abstract][Full Text] [Related]
47. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643 [TBL] [Abstract][Full Text] [Related]
48. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. Liu H; Cadaneanu RM; Lai K; Zhang B; Huo L; An DS; Li X; Lewis MS; Garraway IP Prostate; 2015 May; 75(7):764-76. PubMed ID: 25663004 [TBL] [Abstract][Full Text] [Related]
49. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells. Kim MJ; Choi NY; Lee EK; Kang MS Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871 [TBL] [Abstract][Full Text] [Related]
51. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057 [TBL] [Abstract][Full Text] [Related]
52. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer. Chen Q; Yao L; Burner D; Minev B; Lu L; Wang M; Ma W Clin Transl Oncol; 2019 Apr; 21(4):433-442. PubMed ID: 30218306 [TBL] [Abstract][Full Text] [Related]
54. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay. Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591 [TBL] [Abstract][Full Text] [Related]
55. MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Lapin M; Tjensvoll K; Oltedal S; Buhl T; Gilje B; Smaaland R; Nordgård O Sci Rep; 2016 Jul; 6():28929. PubMed ID: 27432216 [TBL] [Abstract][Full Text] [Related]
56. A label-free DC impedance-based microcytometer for circulating rare cancer cell counting. Choi H; Kim KB; Jeon CS; Hwang I; Lee S; Kim HK; Kim HC; Chung TD Lab Chip; 2013 Mar; 13(5):970-7. PubMed ID: 23340965 [TBL] [Abstract][Full Text] [Related]
57. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer]. Yan Y; Cheng JP; Di LJ; Song GH; Ren J Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003 [TBL] [Abstract][Full Text] [Related]
58. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer. Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142 [TBL] [Abstract][Full Text] [Related]
59. EpCAM expression is an indicator of recurrence in basal-like breast cancer. Agboola AJ; Paish EC; Rakha EA; Powe DG; Macmillan RD; Ellis IO; Green AR Breast Cancer Res Treat; 2012 Jun; 133(2):575-82. PubMed ID: 22002520 [TBL] [Abstract][Full Text] [Related]
60. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application. Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]